CHU de Brest

Running trials

• Not yet recruiting

  Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell Carcinoma

  NCT07888907· Source

• Recruiting

  French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls

  NCT07881016· Source

• Recruiting

  Study of Alloknesia in Atopic Dermatitis

  NCT06923202· Source

• Recruiting

  Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

  NCT07257289· Source

• Recruiting

  Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

  NCT06346197· Phase 3· Source

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Source

• Recruiting

  Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

  NCT06620835· Phase 2· Source

• Recruiting

  BREMISS : Brain Resilience Minor Stroke Study

  NCT06995040· Source

• Recruiting

  Management of COPD Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations

  NCT06523140· Source

• Recruiting

  Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZEPHYR® Valves Versus Endoscopic Volume Reduction With One-stage ZEPHYR® Valves

  NCT06181357· Source

• Recruiting

  Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

  NCT06222762· Source

• Recruiting

  Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  NCT05732831· Phase 1/2· Source

• Recruiting

  Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

  NCT06715267· Source

• Active, not recruiting

  AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

  NCT04881032· Phase 1/2· Source

• Recruiting

  Respiratory Dysbiosis in Preschool Children with Asthma: Predictive of a Severe Form

  NCT05192499· Source

• Recruiting

  Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

  NCT05773638· Source

• Active, not recruiting

  Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

  NCT04127110· Phase 2· Source

• Active, not recruiting

  Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

  NCT04489225· Source

• Active, not recruiting

  Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices

  NCT03366545· Source

• Recruiting

  French National Database of Rare Dermatological Cancers

  NCT03210935· Source

• Recruiting

  Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

  NCT02828202· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• COPD2 recruiting
• Heart failure2 recruiting
• Asthma1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• Autism1 recruiting
• Bipolar disorder1 recruiting
• Depression1 recruiting
• Gastric and esophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroblastoma1 recruiting
• Sarcoma1 recruiting
• Schizophrenia1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

  NCT06919627· Source

• Completed

  Ophthalmological Adverse Events of Tralokinumab in AD

  NCT05682976· Source

• Completed

  BIOSTREAM.HF HeartInsight

  NCT05761249· Source

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· Source

• Completed

  Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

  NCT02579954· Source